Grail shares rose 14% this week on earnings report
Grail shares increased 14% this week due to its first-quarter earnings report.
The company’s stock is down 28% this year following disappointing trial results.
The trial showed a substantial increase in early cancer detection, which may impact FDA approval and insurance coverage.